Page 2 - Franck Admant News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Franck admant. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Franck Admant Today - Breaking & Trending Today

bioMérieux Announces the CE Marking of NEPHROCHECK Test on VIDAS


bioMérieux Announces the CE Marking of NEPHROCHECK Test on VIDAS
in
assay to detect kidney stress in patients at risk of acute kidney injury (AKI).
AKI is a common complication, affecting between 7 and 18% of all hospitalized patients
1 and up to 50% of critically ill patients
2. The condition is associated with a 10-fold increase in hospital mortality and a higher rate of chronic kidney disease among post-op patients
3
While a number of acute risk factors and patient characteristics have been identified which predispose patients to AKI
4, there is no reliable way for a clinician to establish a clear risk profile for any given patient. ....

France General , Franck Admant , Mark Miller , Pierre Boulud , Laurence Heilbronn , Claire Doligez , Olivier Rescaniere , International Society Of Nephrology , Regulatory News , Executive Vice President , Chief Medical Officer , Chief Operating Officer , Clinical Operations , Euronext Paris , பிரான்ஸ் ஜநரல் , குறி மில்லர் , பியர் போழுது , லாரன்ஸ் ஹெயில்பிரான் , சர்வதேச சமூகம் ஆஃப் நெப்ராலஜி , ஒழுங்குமுறை செய்தி , நிர்வாகி துணை ப்ரெஸிடெஂட் , தலைமை மருத்துவ அதிகாரி , தலைமை இயங்குகிறது அதிகாரி , மருத்துவ செயல்பாடுகள் ,

bioMérieux Announces the CE Marking of Its Molecular Biology ARGENE Test for the Simultaneous Detection of SARS-CoV-2, Influenza Viruses A and B, and RSV and hMPV Viruses


bioMérieux Announces the CE Marking of Its Molecular Biology ARGENE Test for the Simultaneous Detection of SARS-CoV-2, Influenza Viruses A and B, and RSV and hMPV Viruses
in vitro diagnostics, has announced the expansion of its ARGENE
range for the real-time PCR (RT-PCR) detection of SARS-CoV-2: the SARS-COV-2 RESPI R-GENE
test has received CE marking and is now commercially available.
This high-throughput test, which can be used on molecular biology platforms in hospital laboratories and private laboratories, allows the simultaneous (multiplex) detection of SARS-CoV-2 and influenza viruses A and B. In addition, it includes a cellular control to check the quality of the sample, providing an important clinical advantage in the context of the pandemic and large-scale sample collection at many different sites. In a single kit, this new test comes with a second RT-PCR analysis performed from the same extraction, for the detection of two other pathogens that often c ....

France General , Midi Pyrees , Franck Admant , Laurence Heilbronn , Claire Doligez , Olivier Rescaniere , Regulatory News , Euronext Paris , பிரான்ஸ் ஜநரல் , லாரன்ஸ் ஹெயில்பிரான் , ஒழுங்குமுறை செய்தி ,